
Several multiple sclerosis drugs covered by Pharmacare in every province except B.C.
When Deborah Stefanek was 38 years old, the mother of four from Kimberley, B.C. was diagnosed with relapsing remitting multiple sclerosis.
That was in 2018, and she hoped a healthy lifestyle would enable her to stay off medication. She changed her diet and started an exercise routine. But after an MRI last fall showed her disease is progressing, Stefanek’s neurologist recommended she begin taking a new medication called Kisempta.
The drug’s manufacturer agreed to temporarily provide the medication free of charge while Stefanek looked into coverage through Pharmacare and private insurance.
“And it came back that my husband’s insurance would only cover 45 per cent of the cost of Kesimpta, which would mean we would have to pay $19,000 out of pocket, because B.C. Pharmacare doesn’t cover it,” said Stefanek.
She was shocked to learn every province in Canada covers Kisempta under their Pharmacare plans except B.C. It’s the same situation for a similar drug called Ocrevus. Stefanek’s friend Andrea Rollheiser, who also has RRMS, was told by her neurologist that Ocrevus is the best drug for her, but it too isn’t covered by B.C. Pharmacare.
The province’s health critic Shirley Bond says that’s unacceptable.
“As patients in British Columbians look across the country, British Columbia is an island on this issue unto itself. And it very hard for people to understand why other jurisdictions, including the one next door to us, can figure out how to cover these drugs,” said Bond, who believes it’s all about cost.
Roche Canada, the maker of Ocrevus, is hoping the B.C. government will reverse course and cover both drugs, which are approved by Health Canada and have been proven to reduce the number and severity of MS relapses.
“All of the other provincial governments have made the decision to make this medicine available, they felt it was a valuable medicine for those living with MS in thier province. And we are equally hopeful that we can have a discussion with the government of British Columbia so that a similar decision can be made,” said Roche Canada president and CEO Brigitte Nolet.
Bond says the opposition will continue to push the government to reconsider its decision on Kesimpta and Ocrevus. And she hopes patients keep speaking out.
“I think it is important for people to speak up and remind the government, and certainly we are doing that as well, that other jurisdictions have figured this out, have approved it. And MS patients, particularly those that suffer from relapse, are being treated differently in B.C. than the rest of the country,” said Bond.
Stefanek says with the bridge financing from the drug company now over, she can only remain on Kestimpa if it’s covered by Pharmacare.
“As it stands right now, we cannot afford that $19,000. So currently, I’m not on the medication,” she said.
And that has her worried she’s at risk for relapse, which could leave her bedridden and unable to care for her kids.
“I need to keep moving, being able to support them and provide for them,” Stefanek said. “If I’m sick, I’m no good to anybody.”
CTVNews.ca Top Stories

Man tied to suspected shooter in Tupac Shakur's 1996 killing arrested in Las Vegas, AP sources say
Las Vegas police have arrested a man in the deadly 1996 drive-by shooting of Tupac Shakur, a long-awaited break in a case that has frustrated investigators and fascinated the public ever since the hip-hop icon was gunned down on the Las Vegas Strip 27 years ago.
Tragedy in real time: The Armenian exodus from Nagorno-Karabakh
For the past five days, vehicles laden with refugees have poured into Armenia, fleeing from the crumbling enclave of Nagorno-Karabakh in neighbouring Azerbaijan. In a special report for CTVNews.ca, journalist Neil Hauer recounts what it's like on the ground in Armenia.
Walking more everyday can significantly lower blood pressure in older adults, study finds
A new study finds walking an additional 3,000 steps per day can significantly reduce high blood pressure in older adults with hypertension.
WATCH Canada likely in 'rounding error recession,' more trouble looming: economist
Statistics Canada has released new data about how the economy started off the third quarter, saying the country's GDP remains essentially unchanged. One economist says it highlights an ongoing trend of weak performance.
OPINION Don Martin: Poilievre picking wrong fights as Liberals struggle under low morale, support
As morale with Justin Trudeau's Liberals goes down the drain with the party's re-election hopes, all Pierre Poilievre needs to do to win is make sure the drain doesn’t get plugged up with doubts about his leadership, writes Don Martin in an exclusive opinion column for CTVNews.ca.
New York City area under state of emergency after storms flood subways, strand people in cars
A potent rush-hour rainstorm swamped the New York metropolitan area on Friday, shutting down parts of the city's subway system, flooding streets and highways, and delaying flights into LaGuardia Airport.
Restoring housing affordability will take 'years and concerted efforts' short of a housing crash: RBC report
Home ownership became slightly more affordable in the second quarter of the year in Canada but it remains 'impossibly high for many,' a new RBC report says.
Toronto family shocked they have to rip out $20K synthetic grass putting green
A Scarborough family said they were shocked to get a notice from the City of Toronto that the artificial grass in their backyard, including a putting green, will have to be ripped out.
U.S. Sen. Dianne Feinstein, an advocate for liberal priorities, dies at age 90
Dianne Feinstein, whose three decades in the Senate made her the longest-serving female U.S. senator in history, has died, according to a source familiar.